Results 151 to 160 of about 195,293 (269)

LDL Apheresis And/or Human Monoclonal Antibodies as Treatment in Se-vere Dyslipoproteinemia

, 2023
olf Bambauer, Ralf Schiel
openalex   +1 more source

Lipoprotein A and the Association With Peripheral Arterial Disease: A Review of the Risk in Peripheral Arterial Disease. [PDF]

Rev Cardiovasc Med
Kar S.
europepmc   +1 more source

Local serum application [PDF]

, 1994
Billing, A., Fritz, Hans, Fröhlich, D., Jochum, Marianne, Konecny, G., Machleidt, W., Schildberg, F. W.   +6 more
core   +1 more source

Atorvastatin compared with simvastatin in patients with severe LDL hypercholesterolaemia treated by regular LDL apheresis [PDF]

, 1999
H.C. Geiss, Klaus G. Parhofer, P. Schwändt   +2 more
openalex   +1 more source

From Risk to Resilience: Transforming Perinatal Management for Women with FH. [PDF]

J Atheroscler Thromb
Ogura M.
europepmc   +1 more source

Complement activation by LDL-apheresis using dextran sulphate [PDF]

, 2017
Blanc, E., Pascual, M., Schifferli, J. A.   +2 more
core  

Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases [PDF]

, 2016
Florian Kronenberg
core   +1 more source

Cholesterol Levels Are Not Associated with Peripheral Blood Stem Cell Mobilization in Healthy Donors. [PDF]

J Clin Med
Seçilmiş S, Aslan Candır B, Bozan E, Yaman S, Uncu Ulu B, Yiğenoğlu TN, İskender D, Kızıl Çakar M, Dal MS, Altuntaş F.   +9 more
europepmc   +1 more source

LDL-apheresis. Potential procedure for prevention and regression of atheromatous vascular lesion.

, 1987
Satoshi Yokoyama, Akira Yamamoto, Rikuro HAYASHI, Makoto Satani   +3 more
openalex   +2 more sources

Side effects in LDL apheresis: types, frequency and clinical relevance [PDF]

, 2011
Knut Tore Lappegård, Anders Hovland
openalex   +1 more source